No Photo Available

Last Update

2016-11-07T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Stephanie Carrington?

Ms. Stephanie J. Carrington

Senior Vice President

ICR , Inc.

Direct Phone: (646) ***-****       

Email: s***@***.com

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

ICR , Inc.

761 Main Avenue

Norwalk, Connecticut 06851

United States

Company Description

Established in 1998, ICR partners with companies to optimize transactions and execute strategic communications programs that achieve business goals, build credibility and enhance long-term enterprise value. The firm's highly differentiated service model, ... more

Find other employees at this company (779)

Background Information

Employment History

Pharmaceuticals , Inc.

SOURCE Medicsight PLC

Inverstor

L.A.M. Pharmaceutical Corp

Vice President, Investor Relations

The Ruth Group

Affiliations

Board of Governors Member
Arbor Realty Trust , Inc.

Active Member
NIRI NY

Education

Bachelors of Arts

Economics and International Relations

Smith College

MBA

Masters of Business Administration

Finance and International Business

New York University's Stern School of Business

Web References (67 Total References)


UroGen Pharma Strengthens Board of Directors and Senior Management Team -Urogen Pharma

www.urogen.com [cached]

Stephanie Carrington, ICR, Inc. stephanie.carrington@icrinc.com 646-277-1282


Stephanie ...

www.genprex.com [cached]

Stephanie Carrington ICR, Inc. 646-277-1282 Stephanie.Carrington@icrinc.com


Stephanie ...

www.bracepharma.com [cached]

Stephanie Carrington ICR Inc. (646) 277-1282 stephanie.carrington@icrinc.com


UroGen Pharma Strengthens Leadership Team and Expands Uro-Oncology Clinical Pipeline with Addition of TLR-7 Agonist Phase 2 Asset -Urogen Pharma

www.urogen.com [cached]

Stephanie Carrington

ICR, Inc.
This entry was posted in News. Bookmark the permalink.


Stephanie Carrington Senior ...

www.icrinc.com [cached]

Stephanie Carrington Senior Vice President

With over 15 years of healthcare investor relations experience combined with prior banking roles, Stephanie provides strategic communications counsel to emerging biotechnology and specialty pharmaceutical companies, both pre- and post-IPO. She combines deep knowledge of the life sciences sector and the investment community to serve as a trusted IR partner for C-suite executives.
Stephanie invests the resources to be well versed in each health care client's corporate strategy and competitive position in order to develop customized programs to raise visibility for the science and growth strategy. Since 2000, she has collaborated with the management teams at such healthcare companies as Intrexon, Clarus Therapeutics, MonoSol Rx, Compugen, Sinovac, Argos Therapeutics, Sirna Therapeutics, Transcept, NeurogesX, and BioFire Diagnostics, to name just a few.
Prior to joining ICR, Stephanie was a Senior Vice President of Investor Relations at The Ruth Group, an Assistant Vice President Morgen-Walke Associates, and a Senior Associate at The Financial Relations Board. Earlier, Stephanie held positions at Alliance Capital Management, Bankers Trust and the Federal Reserve Bank of New York. She earned a BA in Economics and International Relations from Smith College and an MBA in Finance and International Business from New York University's Stern School of Business.
...
Stephanie Carrington Senior Vice President
With over 15 years of healthcare investor relations experience combined with prior banking roles, Stephanie provides strategic communications counsel to emerging biotechnology and specialty pharmaceutical companies, both pre- and post-IPO. She combines deep knowledge of the life sciences sector and the investment community to serve as a trusted IR partner for C-suite executives.
Stephanie invests the resources to be well versed in each health care client's corporate strategy and competitive position in order to develop customized programs to raise visibility for the science and growth strategy. Since 2000, she has collaborated with the management teams at such healthcare companies as Intrexon, Clarus Therapeutics, MonoSol Rx, Compugen, Sinovac, Argos Therapeutics, Sirna Therapeutics, Transcept, NeurogesX, and BioFire Diagnostics, to name just a few.
Prior to joining ICR, Stephanie was a Senior Vice President of Investor Relations at The Ruth Group, an Assistant Vice President Morgen-Walke Associates, and a Senior Associate at The Financial Relations Board. Earlier, Stephanie held positions at Alliance Capital Management, Bankers Trust and the Federal Reserve Bank of New York. She earned a BA in Economics and International Relations from Smith College and an MBA in Finance and International Business from New York University's Stern School of Business.
...
Stephanie Carrington Senior Vice President

Similar Profiles

Other People with this Name

Other people with the name Carrington

Christopher Carrington
ServiceSource Corporation

Sharon Carrington
CSE-Uniserve Limited

Sally Carrington
CIHT Foundation

Rochelle Carrington
Sandler Systems Inc

William Carrington
FedEx Corporation

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory